Published in J Virol on August 01, 1994
Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol (1998) 7.76
The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol (1998) 4.26
Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer. J Virol (1998) 3.25
Adenovirus type 11 uses CD46 as a cellular receptor. J Virol (2003) 2.52
Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol (1996) 2.52
Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes. J Virol (1996) 2.46
The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J Virol (1998) 2.45
Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain. J Virol (1995) 1.88
Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J Virol (1998) 1.88
Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J Virol (1996) 1.85
Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. J Virol (1997) 1.79
Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein. J Virol (2000) 1.65
Coxsackievirus and adenovirus receptor amino-terminal immunoglobulin V-related domain binds adenovirus type 2 and fiber knob from adenovirus type 12. J Virol (1999) 1.62
In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. J Virol (1998) 1.45
Mutations in the DG loop of adenovirus type 5 fiber knob protein abolish high-affinity binding to its cellular receptor CAR. J Virol (1999) 1.37
Domains required for assembly of adenovirus type 2 fiber trimers. J Virol (1996) 1.35
Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog (2010) 1.34
Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber. J Virol (1999) 1.28
Insights into adenovirus host cell interactions from structural studies. Virology (2008) 1.25
Adenovirus 3 penton dodecahedron exhibits structural changes of the base on fibre binding. EMBO J (1996) 1.18
Genetically targeted adenovirus vector directed to CD40-expressing cells. J Virol (2003) 1.18
Metabolic biotinylation of recombinant proteins in mammalian cells and in mice. Mol Ther (2000) 1.16
Canine adenovirus type 2 attachment and internalization: coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway. J Virol (2000) 1.16
Interaction of adenovirus type 5 fiber with the coxsackievirus and adenovirus receptor activates inflammatory response in human respiratory cells. J Virol (2006) 1.09
The human HLA-A*0201 allele, expressed in hamster cells, is not a high-affinity receptor for adenovirus type 5 fiber. J Virol (1999) 1.06
Epitopes and hemagglutination binding domain on subgenus B:2 adenovirus fibers. J Virol (1996) 1.06
Design and cellular internalization of genetically engineered polypeptide nanoparticles displaying adenovirus knob domain. J Control Release (2011) 1.05
The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells. Br J Cancer (2003) 1.04
Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge. J Virol (2003) 1.02
Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation. J Virol (2003) 1.01
Novel fiber-dependent entry mechanism for adenovirus serotype 5 in lacrimal acini. J Virol (2006) 1.00
Labeling of adenovirus particles with PARACEST agents. Bioconjug Chem (2008) 0.99
Adenovirus type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells. J Virol (2001) 0.99
Molecular characterization of hemagglutination domains on the fibers of subgenus D adenoviruses. J Virol (1998) 0.99
A single locus on human chromosome 21 directs the expression of a receptor for adenovirus type 2 in mouse A9 cells. J Virol (1997) 0.97
Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer. J Virol (2007) 0.94
Adenovirus vectors targeting distinct cell types in the retina. Invest Ophthalmol Vis Sci (2009) 0.92
Artificial extension of the adenovirus fiber shaft inhibits infectivity in coxsackievirus and adenovirus receptor-positive cell lines. J Virol (2002) 0.92
Bovine adenovirus type 3 internalization is independent of primary receptors of human adenovirus type 5 and porcine adenovirus type 3. Biochem Biophys Res Commun (2005) 0.91
Molecular characterization of the type-specific gamma-determinant located on the adenovirus fiber. J Virol (1997) 0.91
Improved gene delivery to intestinal mucosa by adenoviral vectors bearing subgroup B and d fibers. J Virol (2006) 0.89
Evolving gene therapy approaches for osteosarcoma using viral vectors: review. Bone (2006) 0.87
Biodistribution of radioiodinated adenovirus fiber protein knob domain after intravenous injection in mice. J Virol (2004) 0.86
Enhancement of adenovirus vector entry into CD70-positive B-cell Lines by using a bispecific CD70-adenovirus fiber antibody. J Virol (2001) 0.85
Development of a targeted gene vector platform based on simian adenovirus serotype 24. J Virol (2010) 0.84
Advanced generation adenoviral virotherapy agents embody enhanced potency based upon CAR-independent tropism. Clin Cancer Res (2006) 0.84
Processing of the l1 52/55k protein by the adenovirus protease: a new substrate and new insights into virion maturation. J Virol (2013) 0.83
Receptor binding sites and antigenic epitopes on the fiber knob of human adenovirus serotype 3. J Virol (1998) 0.82
Retargeting adenoviral vectors to improve gene transfer into tumors. Cancer Gene Ther (2010) 0.81
Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody. J Mol Biol (2009) 0.80
Enhanced Gene Delivery to Human Primary Endothelial Cells Using Tropism-Modified Adenovirus Vectors. Open Gene Ther J (2008) 0.80
Targeting lung cancer using an infectivity enhanced CXCR4-CRAd. Lung Cancer (2006) 0.78
Peptide targeting of adenoviral vectors to augment tumor gene transfer. Cancer Gene Ther (2012) 0.78
Adenoviral gene therapy, radiation, and prostate cancer. Rev Urol (2005) 0.77
Ocular localization and transduction by adenoviral vectors are serotype-dependent and can be modified by inclusion of RGD fiber modifications. PLoS One (2014) 0.77
Ex vivo transfer of the Hoxc-8-interacting domain of Smad1 by a tropism-modified adenoviral vector results in efficient bone formation in a rabbit model of spinal fusion. J Spinal Disord Tech (2010) 0.76
Adenoviral vector-based strategies against infectious disease and cancer. Hum Vaccin Immunother (2016) 0.75
Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice. Sci Rep (2015) 0.75
Thiamine diphosphate binds to intermediates in the assembly of adenovirus fiber knob trimers in Escherichia coli. Protein Sci (2007) 0.75
Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol (1987) 26.70
Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell (1993) 13.21
Stepwise dismantling of adenovirus 2 during entry into cells. Cell (1993) 6.34
A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology (1988) 4.72
Virus-receptor interaction in an adenovirus system. J Virol (1968) 4.69
Human adenovirus-host cell interactions: comparative study with members of subgroups B and C. J Virol (1990) 4.32
Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci U S A (1993) 3.92
Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells. J Virol (1993) 3.29
39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J Biol Chem (1991) 3.17
Molecular composition of the adenovirus type 2 virion. J Virol (1985) 2.72
Evidence for a repeating cross-beta sheet structure in the adenovirus fibre. EMBO J (1983) 2.09
Virus-receptor interaction in the adenovirus system I. Identification of virion attachment proteins of the HeLa cell plasma membrane. J Virol (1981) 1.80
The sequence of adenovirus fiber: similarities and differences between serotypes 2 and 5. Virology (1987) 1.73
Biochemical study of KB-cell receptor for adenovirus. Biochem J (1977) 1.62
Structure of adenovirus fibre. II. Morphology of single fibres. J Mol Biol (1990) 1.58
Virus-receptor interaction in the adenovirus system: characterization of the positive cooperative binding of virions on HeLa cells. J Virol (1985) 1.52
Virus receptor interaction in the adenovirus system. II. Capping and cooperative binding of virions on HeLa cells. J Virol (1983) 1.48
Adenovirus 3 fiber polypeptide gene: implications for the structure of the fiber protein. J Virol (1985) 1.47
New triple-helical model for the shaft of the adenovirus fibre. J Mol Biol (1992) 1.42
Determination of protein molecular weight, hydration, and packing from crystal density. Methods Enzymol (1985) 1.20
Sensitization and neutralization of adenovirus by specific sera against capsid subunits. J Immunol (1972) 1.16
Characterization of adenovirus particles made by deletion mutants lacking the fiber gene. J Virol (1988) 1.07
Structure of adenovirus fibre. I. Analysis of crystals of fibre from adenovirus serotypes 2 and 5 by electron microscopy and X-ray crystallography. J Mol Biol (1990) 1.02
Interactions of KB-cell glycoproteins with an adenovirus capsid protein. Eur J Biochem (1976) 0.98
Mutational and immunochemical analysis of plasminogen activator inhibitor 1. J Biol Chem (1990) 0.91
The adenovirus-mediated delivery of a reporter gene permits the assessment of androgen receptor function in genital skin fibroblast cultures. Stimulation of Gs and inhibition of G(o). J Biol Chem (1993) 0.85
Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest (1993) 9.56
X-ray structure analysis of a membrane protein complex. Electron density map at 3 A resolution and a model of the chromophores of the photosynthetic reaction center from Rhodopseudomonas viridis. J Mol Biol (1984) 8.85
The leucine-rich repeat: a versatile binding motif. Trends Biochem Sci (1994) 7.37
Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. Biochemistry (1981) 6.13
Crystal structure of the outer membrane active transporter FepA from Escherichia coli. Nat Struct Biol (1999) 4.86
A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature (1995) 4.70
Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol (1994) 4.65
Crystal structure of DNA photolyase from Escherichia coli. Science (1995) 4.21
Crystal structure of the cytochrome bc1 complex from bovine heart mitochondria. Science (1997) 4.07
Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci U S A (1993) 3.92
Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol (1984) 3.60
T antigen and template requirements for SV40 DNA replication in vitro. EMBO J (1985) 3.59
Structural mechanism for statin inhibition of HMG-CoA reductase. Science (2001) 3.45
Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 A and 1.0 A resolution. J Mol Biol (1980) 3.25
Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature (1994) 3.24
Proteins with leucine-rich repeats. Curr Opin Struct Biol (1995) 3.18
Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution. J Mol Biol (1974) 3.17
Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. Science (1993) 3.00
Crystallographic structure studies of an IgG molecule and an Fc fragment. Nature (1976) 3.00
Pigment-protein interactions in the photosynthetic reaction centre from Rhodopseudomonas viridis. EMBO J (1986) 2.85
New host cell system for regulated simian virus 40 DNA replication. Mol Cell Biol (1985) 2.82
Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 A resolution. Structure (1994) 2.80
Structure and function of cytochromes P450: a comparative analysis of three crystal structures. Structure (1995) 2.64
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med (1998) 2.54
Atomic structure of single-stranded DNA bacteriophage phi X174 and its functional implications. Nature (1992) 2.44
Structural basis of latency in plasminogen activator inhibitor-1. Nature (1992) 2.33
The crystal structure of the GroES co-chaperonin at 2.8 A resolution. Nature (1996) 2.25
Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. J Biol Chem (1992) 2.19
Structural homology of reaction centers from Rhodopseudomonas sphaeroides and Rhodopseudomonas viridis as determined by x-ray diffraction. Proc Natl Acad Sci U S A (1986) 2.16
The Photosynthetic Reaction Center from the Purple Bacterium Rhodopseudomonas viridis. Science (1989) 2.13
Analysis of optical spectra from single crystals of Rhodopseudomonas viridis reaction centers. Proc Natl Acad Sci U S A (1985) 2.11
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol (2001) 1.94
Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. Circulation (1997) 1.91
Crystal structures of mitochondrial processing peptidase reveal the mode for specific cleavage of import signal sequences. Structure (2001) 1.81
Terminally differentiated neonatal rat myocardial cells proliferate and maintain specific differentiated functions following expression of SV40 large T antigen. J Biol Chem (1988) 1.81
Climate change and the integrity of science. Science (2010) 1.80
Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis. EMBO J (2000) 1.79
Comparison of two highly refined structures of bovine pancreatic trypsin inhibitor. J Mol Biol (1987) 1.77
Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A. J Mol Biol (1996) 1.70
Crystal structure and refinement of cytochrome P450terp at 2.3 A resolution. J Mol Biol (1994) 1.70
Inhibitor binding changes domain mobility in the iron-sulfur protein of the mitochondrial bc1 complex from bovine heart. Proc Natl Acad Sci U S A (1998) 1.65
Serpin-resistant mutants of human tissue-type plasminogen activator. Nature (1989) 1.61
The structure of the ligand-binding domain of neurexin Ibeta: regulation of LNS domain function by alternative splicing. Cell (1999) 1.61
APC2 Cullin protein and APC11 RING protein comprise the minimal ubiquitin ligase module of the anaphase-promoting complex. Mol Biol Cell (2001) 1.59
Crystal structure of the DNA nucleotide excision repair enzyme UvrB from Thermus thermophilus. Proc Natl Acad Sci U S A (1999) 1.56
Structure of the human antibody molecule Kol (immunoglobulin G1): an electron density map at 5 A resolution. J Mol Biol (1976) 1.47
Crystal structure analysis and molecular model of a complex of citrate synthase with oxaloacetate and S-acetonyl-coenzyme A. J Mol Biol (1984) 1.41
Crystallization, crystal structure analysis and atomic model of the complex formed by a human Fc fragment and fragment B of protein A from Staphylococcus aureus. Hoppe Seylers Z Physiol Chem (1978) 1.40
Chromophore-protein interactions and the function of the photosynthetic reaction center: a molecular dynamics study. Proc Natl Acad Sci U S A (1992) 1.40
Nonclassical binding of formylated peptide in crystal structure of the MHC class Ib molecule H2-M3. Cell (1995) 1.37
The crystal structure of the bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase reveals distinct domain homologies. Structure (1996) 1.30
Role of specific simian virus 40 sequences in the nuclease-sensitive structure in viral chromatin. Mol Cell Biol (1985) 1.28
Synapsin I is structurally similar to ATP-utilizing enzymes. EMBO J (1998) 1.27
Dynamics of the aromatic amino acid residues in the globular conformation of the basic pancreatic trypsin inhibitor (BPTI). II. Semi-empirical energy calculations. Biophys Struct Mech (1976) 1.26
Crystal structure analysis and molecular model of human C3a anaphylatoxin. Hoppe Seylers Z Physiol Chem (1980) 1.25
Crystal structure of Rab geranylgeranyltransferase at 2.0 A resolution. Structure (2000) 1.21
Production of simian virus 40 large tumor antigen in bacteria: altered DNA-binding specificity and dna-replication activity of underphosphorylated large tumor antigen. Proc Natl Acad Sci U S A (1989) 1.20
Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. Immunol Lett (2001) 1.17
Deacylated lipopolysaccharide inhibits plasminogen activator inhibitor-1, prostacyclin, and prostaglandin E2 induction by lipopolysaccharide but not by tumor necrosis factor-alpha. J Immunol (1990) 1.16
Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1. Proc Natl Acad Sci U S A (1990) 1.13
A functional model of hepatocyte transplantation for in vivo immunologic studies. Transplantation (1998) 1.13
Cognitive impairment in mild traumatic brain injury: a longitudinal diffusional kurtosis and perfusion imaging study. AJNR Am J Neuroradiol (2012) 1.12
The plug domain of FepA, a TonB-dependent transport protein from Escherichia coli, binds its siderophore in the absence of the transmembrane barrel domain. Proc Natl Acad Sci U S A (2001) 1.12
Crystallographic structural studies of a human Fc fragment. II. A complete model based on a Fourier map at 3.5 A resolution. Hoppe Seylers Z Physiol Chem (1976) 1.12
Experience with various techniques for the refinement of protein structures. Methods Enzymol (1985) 1.12
Engineering of plasminogen activator inhibitor-1 to reduce the rate of latency transition. Nat Struct Biol (1995) 1.09
Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs. Circulation (1998) 1.09
Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain. EMBO J (1988) 1.08
Mechanism of Rab geranylgeranylation: formation of the catalytic ternary complex. Biochemistry (1998) 1.08
Deletion mutants which affect the nuclease-sensitive site in simian virus 40 chromatin. Mol Cell Biol (1982) 1.08
Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats. J Clin Invest (1996) 1.07
Structural adaptations in the specialized bacteriophage T4 co-chaperonin Gp31 expand the size of the Anfinsen cage. Cell (1997) 1.06
Influence of intranasal cocaine on plasma constituents associated with endogenous thrombosis and thrombolysis. Am J Med (1994) 1.06
Adenovirus-mediated transfer of a gene encoding human apolipoprotein A-I into normal mice increases circulating high-density lipoprotein cholesterol. Circulation (1994) 1.02
Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors. Gene Ther (1999) 1.01
Genomic elements involved in transcriptional regulation of the rabbit surfactant protein-A gene. Mol Endocrinol (1993) 0.99
Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity. Biochem J (2001) 0.98
Spoilage of bottled red wine by acetic acid bacteria. Lett Appl Microbiol (2003) 0.97
Inflammation-induced recombinant protein expression in vivo using promoters from acute-phase protein genes. Proc Natl Acad Sci U S A (1995) 0.97
Enteropathogenic Escherichia coli and ulcerative colitis in cotton-top tamarins (Saguinus oedipus). J Infect Dis (2001) 0.96
Transgenic mice expressing rabbit C-reactive protein exhibit diminished chemotactic factor-induced alveolitis. Am J Respir Crit Care Med (1996) 0.96
NMR study in the iron-selenide Rb0.74Fe1.6Se2: determination of the superconducting phase as iron vacancy-free Rb0.3Fe2Se2. Phys Rev Lett (2012) 0.96
Proteomes and transcriptomes of the Apicomplexa--where's the message? Int J Parasitol (2008) 0.95
The structure of the catalytic portion of human HMG-CoA reductase. Biochim Biophys Acta (2000) 0.95
Characterization of a plasminogen activator produced by Acanthamoeba castellanii. Mol Biochem Parasitol (1995) 0.95
Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer. Tissue Antigens (2011) 0.94
'MAD'ly phasing the extracellular domain of the LDL receptor: a medium-sized protein, large tungsten clusters and multiple non-isomorphous crystals. Acta Crystallogr D Biol Crystallogr (2003) 0.94
Structure of the receptor binding domain of adenovirus type 5 fiber protein. Curr Top Microbiol Immunol (1995) 0.93
Genetic modification of the vessel wall. Comparison of surgical and catheter-based techniques for delivery of recombinant adenovirus. Circulation (1994) 0.93
V(D)J rearrangement in Nijmegen breakage syndrome. Mol Immunol (2000) 0.93
The crystal structure of the Bacillus lentus alkaline protease, subtilisin BL, at 1.4 A resolution. J Mol Biol (1992) 0.92
Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells. Arterioscler Thromb Vasc Biol (1999) 0.92
Nanoscale layering of antiferromagnetic and superconducting phases in Rb(2)Fe(4)Se(5) single crystals. Phys Rev Lett (2012) 0.91
Crystallographic structural studies of a human Fc-fragment. I. An electron-density map at 4 A resolution and a partial model. Hoppe Seylers Z Physiol Chem (1976) 0.91
Mutational and immunochemical analysis of plasminogen activator inhibitor 1. J Biol Chem (1990) 0.91